{
    "doi": "https://doi.org/10.1182/blood.V122.21.706.706",
    "article_title": "The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort ",
    "article_date": "November 15, 2013",
    "session_type": "722. Clinical Allogeneic Transplantation - Acute and Chronic GVHD, Immune Reconstitution",
    "abstract_text": "The beneficial anti-leukemic effect of chronic GVHD (CGVHD) is offset by an increased risk of late treatment-related mortality (TRM). Several clinical risk factors have been identified as predictors of outcomes in patients with CGVHD. We previously identified 10 variables significantly associated with TRM and survival in5343 patients with CGVHD transplanted between 1995 and 2004. We then developed a CGVHD CIBMTR risk score using these variables (Arora, M., et al.: Blood, 2011; 117: 6714-6720). Variables included in the score were age, prior acute GVHD, time from HCT to CGVHD, donor type, disease status at transplant, GVHD prophylaxis, gender match, serum bilirubin and Karnofsky score and platelet count at time of diagnosis of CGVHD. Six risk-groups were identified with powerful discriminative ability to predict TRM and survival. In the current study we sought to validate this risk score in an independent dataset of 1007 patients with CGVHD transplanted between 2005 and 2007 using the same inclusion criteria and risk-score calculations. Patients were divided into 4 risk groups (RGs) according to the sum of the overall risk score: RG1 (0-2), RG2 (3-6), RG3 (7-8) and RG4 (9-10) ( Table ), and cumulative incidences of TRM and survival were calculated. TRM and survival at 12 and 24 months after CGVHD for each RG are shown in the Table . We found a strong correlation between CGVHD RG with TRM (p<0.0001) and survival (p<0.0001). Also, TRM and survival were significantly different between each RG ( Figure and Table ). Our study validates the prognostic value of the CIBMTR CGVHD RGs for OS and TRM in a contemporary transplant population. The CIBMTR CGVHD RGs can be used to predict major outcomes and tailor treatment planning. Figure 1 View large Download slide Figure 1 View large Download slide  Close modal Table Outcomes by Risk Group, according to CGVHD CIBMTR risk-score (RS)  . . . Adjusted Overall Survival, (95% CI) after CGVHD . Adjusted Cumulative Incidence, TRM, (95% CI) after CGVHD . Risk Group . Overall RS . Patients, n (%) . 12 months . 24 months . 12 months . 24 months . 1 0-2 213 (21) 88 (84-93) 80 (75-86) 6 (3-10) 9 (5-13) 2 3-6 684 (68) 74 (71-77) 64 (60-67) 15 (18-33) 20 (17-23) 3 7-8 99 (10) 44 (34-54) 37 (28 -48) 33 (24-42) 37 (28-46) 4 9-10 11 (1) 43 (14-73) 43 (14-73) 39 (16-63) 39 (16-63) . . . Adjusted Overall Survival, (95% CI) after CGVHD . Adjusted Cumulative Incidence, TRM, (95% CI) after CGVHD . Risk Group . Overall RS . Patients, n (%) . 12 months . 24 months . 12 months . 24 months . 1 0-2 213 (21) 88 (84-93) 80 (75-86) 6 (3-10) 9 (5-13) 2 3-6 684 (68) 74 (71-77) 64 (60-67) 15 (18-33) 20 (17-23) 3 7-8 99 (10) 44 (34-54) 37 (28 -48) 33 (24-42) 37 (28-46) 4 9-10 11 (1) 43 (14-73) 43 (14-73) 39 (16-63) 39 (16-63) View Large Disclosures: No relevant conflicts of interest to declare.",
    "topics": [
        "graft-versus-host disease, chronic",
        "transplantation",
        "graft-versus-host disease",
        "graft-versus-host disease, acute",
        "serum bilirubin level",
        "serum bilirubin measurement",
        "platelet count measurement",
        "donors"
    ],
    "author_names": [
        "Mary E. D. Flowers, MD",
        "John P. Klein, PhD",
        "Michael T. Hemmer, MS",
        "Peigang Li, MS",
        "Corey S. Cutler, MD",
        "Alvaro Urbano-Ispizua, MD",
        "Daniel R. Couriel, MD",
        "Robert Peter Gale, MD, PhD, DSc, FACP",
        "Yoshihiro Inamoto, MD, PhD",
        "Joseph H. Antin, MD",
        "Brian J. Bolwell, MD",
        "Michael Boyiadzis, MD",
        "MHSc",
        "Jean-Yves Cahn, MD",
        "Mitchell S. Cairo, MD",
        "Luis M. Isola, MD",
        "David A. Jacobsohn, MD",
        "Madan Jagasia, MBBS, MS",
        "Thomas R. Klumpp, MD",
        "Effie W. Petersdorf, MD",
        "Stella Santarone, MD",
        "Harry C. Schouten, MD, PhD",
        "John R. Wingard, MD, PhD",
        "Stephen Spellman",
        "MBS",
        "Daniel J. Weisdorf, MD",
        "Steven Z. Pavletic, MD",
        "Stephanie J. Lee, MD, MPH",
        "Mary M. Horowitz, MD, MS",
        "Mukta Arora, MD, MS"
    ],
    "author_dict_list": [
        {
            "author_name": "Mary E. D. Flowers, MD",
            "author_affiliations": [
                "Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "John P. Klein, PhD",
            "author_affiliations": [
                "Center for International Blood & Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michael T. Hemmer, MS",
            "author_affiliations": [
                "Center for International Blood & Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Peigang Li, MS",
            "author_affiliations": [
                "Center for International Blood & Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, WI, USA, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Corey S. Cutler, MD",
            "author_affiliations": [
                "Dana-Farber Cancer Institute, Boston, MA, USA, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alvaro Urbano-Ispizua, MD",
            "author_affiliations": [
                "Hematology, Hospital Clinic of Barcelona, Barcelona, Spain, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniel R. Couriel, MD",
            "author_affiliations": [
                "Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Robert Peter Gale, MD, PhD, DSc, FACP",
            "author_affiliations": [
                "Section of Hematology, Division of Experimental Medicine, Department of Medicine, Imperial College, London, United Kingdom, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Yoshihiro Inamoto, MD, PhD",
            "author_affiliations": [
                "Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA, "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joseph H. Antin, MD",
            "author_affiliations": [
                "Dana-Farber Cancer Institute, Boston, MA, USA, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Brian J. Bolwell, MD",
            "author_affiliations": [
                "Leukemia Program, Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michael Boyiadzis, MD",
            "author_affiliations": [],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "MHSc",
            "author_affiliations": [
                "Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jean-Yves Cahn, MD",
            "author_affiliations": [
                "Department of Hematology, University Hospital, Grenoble, France, "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mitchell S. Cairo, MD",
            "author_affiliations": [
                "New York Presbyterian Hospital at Cornell, New York Medical College, Valhalla, NY, USA, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luis M. Isola, MD",
            "author_affiliations": [
                "Division of Blood and Marrow Transplantation, The Mount Sinai Medical Center, New York, NY, USA, "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "David A. Jacobsohn, MD",
            "author_affiliations": [
                "Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA, "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Madan Jagasia, MBBS, MS",
            "author_affiliations": [
                "Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA, "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Thomas R. Klumpp, MD",
            "author_affiliations": [
                "Temple Bone Marrow Transplant Program, Philadelphia, PA, USA, "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Effie W. Petersdorf, MD",
            "author_affiliations": [
                "Fred Hutchinson Cancer Research Center, Seattle, WA, USA, "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stella Santarone, MD",
            "author_affiliations": [
                "Ospedale Civile BMT Center Pescara, Pescara, Italy, "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Harry C. Schouten, MD, PhD",
            "author_affiliations": [
                "Academische Ziekenhuis Maastricht, Maastricht, Netherlands, "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "John R. Wingard, MD, PhD",
            "author_affiliations": [
                "University of Florida, Gainesville, FL, USA, "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stephen Spellman",
            "author_affiliations": [],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "MBS",
            "author_affiliations": [
                "Center for International Blood & Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN, USA, "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniel J. Weisdorf, MD",
            "author_affiliations": [
                "Center for International Blood & Marrow Transplant Research, University of Minnesota Medical Center, Fairview, Minneapolis, MN, USA, "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Steven Z. Pavletic, MD",
            "author_affiliations": [
                "Experimental Transplant and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA, "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stephanie J. Lee, MD, MPH",
            "author_affiliations": [
                "Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA, "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mary M. Horowitz, MD, MS",
            "author_affiliations": [
                "Center for International Blood & Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA, "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mukta Arora, MD, MS",
            "author_affiliations": [
                "Blood and Marrow Transplant Program, University of Minnesota Medical Center, Fairview, Minneapolis, MN, USA"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-25T15:43:22",
    "is_scraped": "1"
}